+36.1%
MRNA vs NTAP
+165.5%
-129.4%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | NTAP | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +8.5% | -3.2% | +4.5% |
| 7D | -1.1% | +7.4% | -8.5% | -1.8% |
| 30D | +126.1% | -1.4% | +127.5% | +124.9% |
| 3M | +190.0% | +24.6% | +165.5% | +166.2% |
| 6M | +157.2% | +105.9% | +51.3% | +91.4% |
| YTD | +388.2% | +88.5% | +299.7% | +273.4% |
| 1Y | +467.0% | +62.1% | +404.9% | +361.9% |
| 3Y | +36.1% | +169.1% | -133.0% | -3.7% |
| All | +36.1% | +165.5% | -129.4% | -3.7% |
Cumulative growth
Daily Returns
Daily percentage return beside NTAP.
Daily Out/Under-Performance
Portfolio return minus NTAP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NTAP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded NTAP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling